T1	Intervention 211 240	Patients with type 2 diabetes
T2	Intervention 672 748	5238 patients with type 2 diabetes who had evidence of macrovascular disease
T3	Intervention 753 813	recruited patients from primary-care practices and hospitals
T4	Intervention 2410 2484	patients with type 2 diabetes who have a high risk of macrovascular events
